Express Scripts (ESRX)  is buying its larger competitor Medco Health Solutions  (MHS).   Express Scripts  is a pharmacy benefit manager.   The Wall Street likes the deal and currently  Express Scripts  is up over $3.00.  

Our analysis shows that there may be serious anti trust issues here that the Wall Street has not thought about.   Normally we would have given a signal right here, but our long experience with trading Express Scripts  stock shows that there is a propensity for a short squeeze.   We will not short here, but will watch Express Scripts  for a short squeeze.   If a short squeeze occurs, we will short this stock at the end of the short squeeze.  

An actionable signal will be provided    in real-time on the Real Time Feed of the ZYX Short Sell Change Alert.